[go: up one dir, main page]

DK1567137T3 - Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner - Google Patents

Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner

Info

Publication number
DK1567137T3
DK1567137T3 DK03772659T DK03772659T DK1567137T3 DK 1567137 T3 DK1567137 T3 DK 1567137T3 DK 03772659 T DK03772659 T DK 03772659T DK 03772659 T DK03772659 T DK 03772659T DK 1567137 T3 DK1567137 T3 DK 1567137T3
Authority
DK
Denmark
Prior art keywords
resveratrol
manufacture
treatment
influenza virus
virus infections
Prior art date
Application number
DK03772659T
Other languages
Danish (da)
English (en)
Inventor
Enrico Garaci
Anna T Palamara
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1567137T3 publication Critical patent/DK1567137T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03772659T 2002-11-06 2003-10-14 Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner DK1567137T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
PCT/IT2003/000626 WO2004041260A1 (fr) 2002-11-06 2003-10-14 Utilisation de resveratrol pour la preparation d'un medicament utile pour le traitement des infections virales de la grippe

Publications (1)

Publication Number Publication Date
DK1567137T3 true DK1567137T3 (da) 2008-04-28

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03772659T DK1567137T3 (da) 2002-11-06 2003-10-14 Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner

Country Status (18)

Country Link
US (1) US8431617B2 (fr)
EP (1) EP1567137B1 (fr)
JP (1) JP4589118B2 (fr)
KR (1) KR101060331B1 (fr)
AR (1) AR041891A1 (fr)
AT (1) ATE381929T1 (fr)
AU (1) AU2003279551A1 (fr)
CA (1) CA2504872C (fr)
CY (1) CY1107302T1 (fr)
DE (1) DE60318327T2 (fr)
DK (1) DK1567137T3 (fr)
ES (1) ES2295660T3 (fr)
IT (1) ITRM20020562A1 (fr)
MX (1) MXPA05004628A (fr)
PL (1) PL217628B1 (fr)
PT (1) PT1567137E (fr)
TW (1) TWI337863B (fr)
WO (1) WO2004041260A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951285A2 (fr) * 2005-11-18 2008-08-06 Ares Trading S.A. L interferon dans la grippe
US8629283B2 (en) * 2008-03-06 2014-01-14 Icahn School Of Medicine At Mount Sinai Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof
EP2349305A4 (fr) * 2008-11-04 2012-08-22 Metaproteomics Llc Compositions phytochimiques et procédés d'activation de l'amp kinase
WO2010123527A2 (fr) * 2008-12-19 2010-10-28 The Regents Of The University Of California Utilisation d'inhibiteurs du facteur de croissance épidermique dans le cadre du traitement d'une infection virale
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
WO2011150413A1 (fr) 2010-05-28 2011-12-01 Mount Sinai School Of Medicine Composés antiviraux et leurs utilisations
CA2850597A1 (fr) * 2011-09-30 2013-04-04 Vanderbilt University Therapies antivirales avec des inhibiteurs de phospholipase d
PL2952180T3 (pl) 2014-06-04 2017-05-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. STAŁE FORMULACJE ZAWIERAJĄCE RESWERATROL I WIELONIENASYCONE KWASY TŁUSZCZOWE OMEGA-3 (n-3 PUFA)
EP2952209B1 (fr) 2014-06-04 2018-03-28 Alfasigma S.p.A. Formulations homogènes comprenant des acides gras polyinsaturés omega-3 (n-3 PUFA) et de resvératrol pour administration orale
EP3120842A1 (fr) 2015-07-20 2017-01-25 Opterion Health AG Fluide thérapeutique péritonéal
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
EP4132277B1 (fr) * 2020-04-05 2025-11-26 Mong, Michael Systèmes et méthodes pour le traitement du coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es) 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
CA2380924C (fr) 1999-08-13 2008-02-19 University Of Maryland Biotechnology Institute Compositions pour le traitement des infections virales, et procedes correspondants

Also Published As

Publication number Publication date
KR20050071627A (ko) 2005-07-07
DE60318327T2 (de) 2008-12-18
MXPA05004628A (es) 2005-09-08
DE60318327D1 (de) 2008-02-07
US20050239906A1 (en) 2005-10-27
ATE381929T1 (de) 2008-01-15
TWI337863B (en) 2011-03-01
EP1567137B1 (fr) 2007-12-26
TW200501935A (en) 2005-01-16
PL217628B1 (pl) 2014-08-29
CA2504872A1 (fr) 2004-05-21
WO2004041260A1 (fr) 2004-05-21
CY1107302T1 (el) 2012-11-21
ES2295660T3 (es) 2008-04-16
CA2504872C (fr) 2011-07-05
PL377557A1 (pl) 2006-02-06
KR101060331B1 (ko) 2011-08-30
AU2003279551A1 (en) 2004-06-07
EP1567137A1 (fr) 2005-08-31
AR041891A1 (es) 2005-06-01
JP2006507295A (ja) 2006-03-02
PT1567137E (pt) 2008-02-19
US8431617B2 (en) 2013-04-30
JP4589118B2 (ja) 2010-12-01
ITRM20020562A1 (it) 2004-05-07

Similar Documents

Publication Publication Date Title
DK1542748T3 (da) Engangssprøjte
IS7894A (is) Skammtaform með ofnæmisvaka
EP1495141A4 (fr) Therapeutique du vih
DK1545662T3 (da) Lægemiddelindgivelsessystem
DE602004018587D1 (de) Staubschützende Wegwerfmaske
DK1633726T3 (da) Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
NO20054608D0 (no) Influensavirusvaksine
NO20052058D0 (no) Behandling av influensa.
NO20016368D0 (no) Respiratorisk syncytialvirus-replikasjonsinhibitorer
NO20016369D0 (no) Respiratorisk syncytialvirus-replikasjonsinhibitorer
NO20016370L (no) Respiratorisk syncytialvirus-replikasjonsinhibitorer
DK1567137T3 (da) Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner
DK1601359T3 (da) Væskeformige, farmaceutiske formuleringer af palonosetron
NO20044322L (no) Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament
DE602004012448D1 (de) Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus
DK1709075T3 (da) Behandling af virusinfektioner
CL2004000261A1 (es) Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica.
EP1692279A4 (fr) Preparations de virus contenant un conservateur
ES1053382Y (es) Protesis dilatadora del vestibulo nasal.
DE602004022810D1 (de) Mehrdosis-inhalator
DK1494650T3 (da) Farmaceutisk formulering, der indeholder melatonin
DK1541137T3 (da) Transdermalt delivery system af gestoden
DK2388315T3 (da) Anvendelse af et myxomvirus, som ikke eksprimerer funktionelt M135R, til terapeutisk behandling
DE50212677D1 (de) Unidirektionales zählwerk
DK1446131T3 (da) Anvendelse af specifik dosis af fondaparinux-natrium til behandling af ACS